Access to European Union law
<a href="https://eur-lex.europa.eu/content/help/eurlex-content/experimental-features.html" target="_blank">More about the experimental features corner</a>
Choose the experimental features you want to try
EUR-Lex
Access to European Union law

This document is an excerpt from the EUR-Lex website

You are here
Use quotation marks to search for an "exact phrase". Append an asterisk (*) to a search term to find variations of it (transp*, 32019R*). Use a question mark (?) instead of a single character in your search term to find variations of it (ca?e finds case, cane, care).
Search tips
Need more search options? Use the Advanced search

Document 32019R0831

Commission Regulation (EU) 2019/831 of 22 May 2019 amending Annexes II, III and V to Regulation (EC) No 1223/2009 of the European Parliament and of the Council on cosmetic products (Text with EEA relevance.)

C/2019/3717

IO L 137, 23.5.2019, p. 29–63 (BG, ES, CS, DA, DE, ET, EL, EN, FR, HR, IT, LV, LT, HU, MT, NL, PL, PT, RO, SK, SL, FI, SV)

Legal status of the document In force

ELI: http://data.europa.eu/eli/reg/2019/831/oj

Date of document:
22/05/2019; Dáta ar glacadh
Date of effect:
12/06/2019; Teacht i bhfeidhm Dáta foilsithe +20 Féach Airt. 2
Date of end of validity:
No end date
Author:
An Coimisiún Eorpach, Ard-Stiúrthóireacht um an Margadh Inmheánach, Tionsclaíocht, Fiontraíocht agus Fiontair Bheaga agus Mheánmhéide
Responsible body:
GROW
Form:
Rialachán
Additional information:
Ábharthacht maidir le LEE
Treaty:
An Conradh ar Fheidhmiú an Aontais Eorpaigh
Legal basis:
Link
Link
Link
Select all documents mentioning this document
Modifies:
Relation Act Comment Subdivision concerned From To
Modifies 32009R1223 Athchur iarscríbhinn II pointe 395 12/06/2019
Modifies 32009R1223 Cur le iarscríbhinn II Téacs 12/06/2019
Modifies 32009R1223 Athchur iarscríbhinn III pointe 12 12/06/2019
Modifies 32009R1223 Aisghairm iarscríbhinn III pointe 13 12/06/2019
Modifies 32009R1223 Aisghairm iarscríbhinn III pointe 1a 12/06/2019
Modifies 32009R1223 Aisghairm iarscríbhinn III pointe 1b 12/06/2019
Modifies 32009R1223 Cur le iarscríbhinn III pointe 311 12/06/2019
Modifies 32009R1223 Cur le iarscríbhinn III pointe 312 12/06/2019
Modifies 32009R1223 Aisghairm iarscríbhinn III pointe 51 12/06/2019
Modifies 32009R1223 Aisghairm iarscríbhinn III pointe 7 12/06/2019
Modifies 32009R1223 Athchur iarscríbhinn V brollach 2 12/06/2019
Modifies 32009R1223 Athchur iarscríbhinn V pointe 28 12/06/2019
Modifies 32009R1223 Aisghairm iarscríbhinn V pointe 31 12/06/2019
Modifies 32009R1223 Aisghairm iarscríbhinn V pointe 40 12/06/2019
Modifies 32009R1223 Aisghairm iarscríbhinn V pointe 41 12/06/2019
Modifies 32009R1223 Aisghairm iarscríbhinn V pointe 5 12/06/2019
Instruments cited:
Link

23.5.2019   

EN

Official Journal of the European Union

L 137/29

COMMISSION REGULATION (EU) 2019/831

of 22 May 2019

amending Annexes II, III and V to Regulation (EC) No 1223/2009 of the European Parliament and of the Council on cosmetic products

(Text with EEA relevance)

THE EUROPEAN COMMISSION,

Having regard to the Treaty on the Functioning of the European Union,

Having regard to Regulation (EC) No 1223/2009 of the European Parliament and of the Council of 30 November 2009 on cosmetic products (1), and in particular Article 15(1), the fourth subparagraph of Article 15(2) and Article 31(1) thereof,

Whereas:

(1)

Regulation (EC) No 1272/2008 of the European Parliament and of the Council (2) provides for a harmonised classification of substances as carcinogenic, mutagenic or toxic for reproduction (CMR) based on a scientific assessment by the Risk Assessment Committee of the European Chemicals Agency. The substances are classified as CMR substances of category 1A, CMR substances of category 1B or CMR substances of category 2 depending on the level of evidence of their CMR properties.

(2)

Article 15 of Regulation (EC) No 1223/2009 provides that substances which have been classified as CMR substances of category 1A, category 1B or category 2 under Part 3 of Annex VI to Regulation (EC) No 1272/2008 (CMR substances) are prohibited from use in cosmetic products. A CMR substance may however be used in cosmetic products where the conditions laid down in the second sentence of Article 15(1) or in the second subparagraph of Article 15(2) of Regulation (EC) No 1223/2009 are fulfilled. This Regulation implements Regulation (EC) No 1223/2009. Only the Court of Justice of the European Union is entitled to interpret Union law, including Article 15 of Regulation (EC) No 1223/2009.

(3)

In order to uniformly implement the prohibition of CMR substances within the internal market, to ensure legal certainty, in particular for economic operators and national competent authorities and to ensure a high level of protection of human health, all CMR substances should be included in the list of prohibited substances in Annex II to Regulation (EC) No 1223/2009 and, where relevant, deleted from the lists of restricted or authorised substances in Annexes III and V to that Regulation. Where the conditions laid down in the second sentence of Article 15(1) or the second subparagraph of Article 15(2) of Regulation (EC) No 1223/2009 are fulfilled, the lists of restricted or authorised substances in Annexes III and V to that Regulation should be amended accordingly.

(4)

This Regulation covers the substances which have been classified as CMR substances pursuant to Regulation (EC) No 1272/2008 as at 1 December 2018, when Commission Regulation (EU) 2017/776 (3) became applicable.

(5)

Concerning certain CMR substances for which a request for use in cosmetic products by way of exception has been submitted, it has not been established that all the conditions provided for in the second sentence of Article 15(1) or the second subparagraph of Article 15(2) of Regulation (EC) No 1223/2009 are fulfilled. This concerns Quaternium-15, Chloroacetamide, Dichloromethane, Formaldehyde, Perboric acid and Sodium perborate compounds

(6)

The substance Methenamine 3-chloroallylochloride, with the International Nomenclature of Cosmetic Ingredients (INCI) name Quaternium-15, is currently listed in entry 31 of Annex V to Regulation (EC) No 1223/2009 as allowed in a concentration of up to 0,2 % in ready for use preparation. Quaternium-15 is a mixture of cis and trans isomers of which the cis-isomer has been classified as a CMR substance of category 2 by Commission Regulation (EC) No 790/2009 (4). The classification became applicable on 1 December 2010. In accordance with the second sentence of Article 15(1) of Regulation (EC) No 1223/2009, a substance classified in category 2 may be used in cosmetic products where the substance has been evaluated by the Scientific Committee on Consumer Safety (SCCS) and found safe for use in cosmetic products. On 13 and 14 December 2011, the SCCS issued a scientific opinion on Quaternium-15 (cis-isomer) (5), which concluded that on the basis of the available data the safety of Quaternium-15 for use in cosmetic products cannot be established. In light of the classification of the cis-isomer present in Quaternium-15 as a CMR substance of category 2 and the opinion of the SCCS, Quaternium-15 should be deleted from the list of preservatives allowed in cosmetic products in Annex V to Regulation (EC) No 1223/2009 and added to the list of substances prohibited in cosmetic products in Annex II to that Regulation.

(7)

The substance 2-Chloroacetamide, with the INCI name Chloroacetamide, is currently listed in entry 41 of Annex V to Regulation (EC) No 1223/2009 as allowed in a concentration of up to 0,3 % in ready for use preparation. Chloroacetamide has been classified as a CMR substance of category 2 under Regulation (EC) No 1272/2008. The classification became applicable before 1 December 2010, at which date Titles II, III and IV of Regulation (EC) No 1272/2008 became applicable in respect of substances. In accordance with the second sentence of Article 15(1) of Regulation (EC) No 1223/2009, a substance classified in category 2 may be used in cosmetic products where the substance has been evaluated by the SCCS and found safe for use in such products. On 22 March 2011, the SCCS issued a scientific opinion on Chloroacetamide (6) which concluded that, on the basis of the available data, the substance is not safe for consumers when used in a concentration of up to 0,3 % w/w in cosmetic products. In light of the classification as a CMR substance of category 2 and the opinion of the SCCS, Chloroacetamide should be deleted from the list of preservatives allowed in cosmetic products in Annex V to Regulation (EC) No 1223/2009 and added to the list of substances prohibited in cosmetic products in Annex II to that Regulation.

(8)

The substance Dichloromethane is currently listed in entry 7 of Annex III to Regulation (EC) No 1223/2009 as allowed in cosmetic products in a concentration of up to 35 % in ready for use preparation. Dichloromethane has been classified as a CMR substance of category 2 under Regulation (EC) No 1272/2008. The classification became applicable before 1 December 2010. In accordance with the second sentence of Article 15(1) of Regulation (EC) No 1223/2009, a substance classified in category 2 may be used in cosmetic products where the substance has been evaluated by the SCCS and found safe for use in such products. On 11 December 2012, the SCCS issued a scientific opinion on Dichloromethane (7). On 25 March 2015, the SCCS issued a new opinion (8) which was revised on 28 October 2015. In that revised opinion the SCCS concluded that the use of Dichloromethane in a concentration of up to 35 % in hair sprays and its use in spray formulations in general is not considered safe for the consumer. In light of the classification as a CMR substance of category 2 and the opinion of the SCCS, and since no other uses of Dichloromethane in cosmetic products are known and have been covered by the SCCS opinion, the substance should be deleted from the list of restricted substances in Annex III to Regulation (EC) No 1223/2009 and added to the list of substances prohibited in cosmetic products in Annex II to that Regulation.

(9)

The substance Formaldehyde is currently listed in entry 13 of Annex III to Regulation (EC) No 1223/2009 as allowed in nail hardening products in a concentration of up to 5 % in ready for use preparation. It is also currently listed in entry 5 of Annex V to Regulation (EC) No 1223/2009 as allowed in oral products in a concentration of up to 0,1 % and in other products in a concentration of up to 0,2 %. Formaldehyde has been classified as a CMR substance of category 1B by Commission Regulation (EU) No 605/2014 (9). The classification became applicable on 1 January 2016. In accordance with the second subparagraph of Article 15(2) of Regulation (EC) No 1223/2009, substances classified as CMR substances of category 1A or 1B may be used in cosmetic products by way of exception where, subsequent to their classification as CMR substances, certain conditions are fulfilled, including the conditions that no suitable alternative substances are available, that an application is made for a particular use of the product category with a known exposure and that the substance has been evaluated and found safe by the SCCS. On 7 November 2014, the SCCS concluded in its opinion (10) that ‘nail hardeners with a maximum concentration of about 2,2 % free formaldehyde can be used safely to harden or strengthen nails’. However, since it has not been established that there are no suitable alternative substances available for the purpose of hardening nails, Formaldehyde should be deleted from the list of restricted substances in Annex III to Regulation (EC) No 1223/2009. Since no application was made for other uses of Formaldehyde, the substance should be deleted from the list of preservatives allowed in cosmetic products in Annex V to that Regulation. Formaldehyde should also be added to the list of substances prohibited in cosmetic products in Annex II to Regulation (EC) No 1223/2009.

(10)

Perboric acid and Sodium perborate compounds are covered by the hydrogen peroxide releasing substances currently listed in entry 12 of Annex III to Regulation (EC) No 1223/2009. They have been classified as CMR substances of category 1B by Regulation (EC) No 790/2009. The classification became applicable by 1 December 2010. A request for the application of the second subparagraph of Article 15(2) of Regulation (EC) No 1223/2009 was submitted for the use of those substances in oxidative hair dye formulations. On 22 June 2010, the SCCS concluded in its opinion (11) that the ‘general restrictions applicable to hydrogen peroxide releasing substances should apply to sodium perborate and perboric acid and that the use of sodium perborates as an ingredient in oxidative hair dye formulations with a maximum on-head concentration of 3 % will not pose a risk to the health of the consumer’. However, since it has not been established that there are no suitable alternative substances available for the purpose of oxidation of hair, Perboric acid and Sodium perborate compounds should be deleted from the list of restricted substances in Annex III to Regulation (EC) No 1223/2009 and added to the list of substances prohibited in cosmetic products in Annex II to that Regulation.

(11)

Concerning certain substances which were classified as CMR substances under Regulation (EC) No 1272/2008 and for which a request for the application of the second sentence of Article 15(1) of Regulation (EC) No 1223/2009 has been submitted, it has been established that the condition provided for in that provision is fulfilled. This concerns Trimethylbenzoyl diphenylphosphine oxide, Furfural and Polyaminopropyl biguanide.

(12)

The substance Diphenyl(2,4,6-trimethylbenzoyl)phosphine oxide, with the INCI name Trimethylbenzoyl diphenylphosphine oxide (TPO), is currently not included in the Annexes to Regulation (EC) No 1223/2009. TPO has been classified as a CMR substance of category 2 by Commission Regulation (EU) No 618/2012 (12). The classification became applicable on 1 December 2013. On 27 March 2014, the SCCS issued a scientific opinion (13) which concluded that TPO is safe when used as a nail modelling product in a concentration of up to 5,0 % but that it is however a moderate skin sensitizer. Considering the skin sensitising properties of TPO and the high risk of exposure through skin contact in case of self-application of nail products, the use of TPO should be restricted to professionals only. In light of those elements, TPO should be added to the list of restricted substances in Annex III to Regulation (EC) No 1223/2009 for professional use in artificial nail systems with a maximum concentration of 5 %.

(13)

The substance 2-Furaldehyde, with the INCI name Furfural, is used as a fragrance or flavour ingredient in cosmetic products and is currently not included in the Annexes to Regulation (EC) No 1223/2009. It has been classified as a CMR substance of category 2 under Regulation (EC) No 1272/2008. The classification became applicable before 1 December 2010. On 27 March 2012, the SCCS concluded in its opinion (14) that the use of Furfural in a concentration of up to 10 ppm (0,001 %) in ready for use preparation, including oral products, does not pose any risk to the health of the consumer. In light of the classification of Furfural as a CMR substance of category 2 and the opinion of the SCCS, Furfural should be added to the list of restricted substances in Annex III to Regulation (EC) No 1223/2009 with a maximum concentration of 0,001 %.

(14)

The substance Polyhexamethylene biguanide hydrochloride (PHMB), with the INCI name Polyaminopropyl Biguanide, is currently listed as a preservative in entry 28 of Annex V to Regulation (EC) No 1223/2009 with a maximum concentration of 0,3 %. It has been classified as a CMR substance of category 2 by Commission Regulation (EU) No 944/2013 (15). The classification became applicable on 1 January 2015. On 18 June 2014, the SCCS adopted an opinion (16) which concluded that on the basis of the data available, PHMB is not safe for consumers when used as a preservative in all cosmetic products at a maximum concentration of 0,3 %. However, the SCCS opinion also concluded that the safe use could be based on a lower use concentration and/or restrictions with regard to cosmetic products' categories and that dermal absorption studies on additional representative cosmetic formulations are needed. On 7 April 2017, the SCCS adopted a new opinion (17) which concluded that, based on the data provided, the use of PHMB as a preservative in all cosmetic products up to 0,1 % is safe but that its use in sprayable formulations is not advised. In light of the classification of PHMB as a CMR substance of category 2 and of the new SCCS opinion, PHMB should be authorised as a preservative in all cosmetic products, except in applications that may lead to exposure of the end-user's lungs by inhalation, with a maximum concentration of 0,1 %. The conditions set out in Annex V to Regulation (EC) No 1223/2009 should be adapted accordingly.

(15)

Concerning a large group of substances which were classified as CMR substances under Regulation (EC) No 1272/2008, no request for use in cosmetic products by way of exception has been submitted. Those substances should be included in the list of prohibited substances in Annex II to Regulation (EC) No 1223/2009 and, where relevant, deleted from the lists of restricted or authorised substances in Annexes III and V to that Regulation. This concerns, inter alia, some boron compounds currently listed in entries 1a and 1b of Annex III to Regulation (EC) No 1223/2009.

(16)

Some boron compounds currently listed in entries 1a and 1b of Annex III to Regulation (EC) No 1223/2009 and Dibutyltin hydrogen borate have been classified as CMR substances of category 1B by Regulation (EC) No 790/2009. The classification became applicable by 1 December 2010. In accordance with the second subparagraph of Article 15(2) of Regulation (EC) No 1223/2009, substances classified as CMR substances of category 1A or 1B may be used in cosmetic products by way of exception where, subsequent to their classification as CMR substances, certain conditions are fulfilled. On 22 June 2010, the SCCS issued an opinion (18) which concluded that some of the boron compounds currently listed in entries 1a and 1b of Annex III to that Regulation are safe for use in cosmetics under certain conditions. However, since no application for a particular use was made and since it has not been established that there are no suitable alternative substances available for the purpose of the relevant uses listed in Annex III to Regulation (EC) No 1223/2009, those boron compounds should be deleted from the list of restricted substances in Annex III to that Regulation and added to the list of substances prohibited in cosmetic products in Annex II to Regulation (EC) No 1223/2009. As regards Dibutyltin hydrogen borate, no application for a particular use was made and it has not been found safe by the SCCS. That substance should therefore be added to the list of substances prohibited in cosmetic products in Annex II to Regulation (EC) No 1223/2009.

(17)

Article 31(1) of Regulation (EC) No 1223/2009 provides that where there is a potential risk to human health, arising from the use of substances in cosmetic products, which needs to be addressed on a Community-wide basis, the Commission may, after consulting the SCCS, amend Annexes II to VI to that Regulation accordingly. The Commission has consulted the SCCS on the safety of certain substances which are similar from a chemical perspective to substances classified as CMR substances of categories 1A, 1B or 2. This concerns certain boron compounds as well as Paraformaldehyde and Methylene Glycol.

(18)

Certain boron compounds currently listed in entries 1a and 1b of Annex III to Regulation (EC) No 1223/2009, other than those referred to in Recital 16, have not been classified as CMR substances. On 12 December 2013, the SCCS issued an opinion on borates, tetraborates and octaborates (19), where it concluded that those substances, as well as other boric acid salts or esters, such as MEA-borate, MIPA-borate, potassium borate, trioctyldodecyl borate and zinc borate, form boric acid in aqueous solutions and that therefore the general restrictions applicable to boric acid should apply to the whole group of borates, tetraborates and octaborates. Boric acid has been classified as a CMR substance of category 1B by Regulation (EC) No 790/2009. The classification became applicable by 1 December 2010. In light of the opinion of the SCCS, the whole group of borates, tetraborates and octaborates, except the substances in that group that have been classified as CMR substances, as well as other boric acid salts or esters, should be deleted from the list of restricted substances in Annex III to Regulation (EC) No 1223/2009 and added to the list of substances prohibited in cosmetic products in Annex II to that Regulation.

(19)

The substance Paraformaldehyde is currently listed in entry 5 of Annex V to Regulation (EC) No 1223/2009 but, contrary to Formaldehyde, it has not been classified as a CMR substance. The substance Methylene Glycol is currently not included in the Annexes to Regulation (EC) No 1223/2009. On 26–27 June 2012, the SCCS adopted an opinion on Methylene Glycol (20) which established that Methylene Glycol is rapidly reversible under a variety of conditions to form Formaldehyde in aqueous solutions and that Paraformaldehyde can depolymerise to form Formaldehyde by heating or drying. In light of the opinion of the SCCS, there is a potential risk to human health arising from the use of those substances in cosmetic products. Paraformaldehyde should therefore be deleted from the list of preservatives allowed in cosmetic products in Annex V to Regulation (EC) No 1223/2009 and Paraformaldehyde and Methylene Glycol should be added to the list of substances prohibited in cosmetic products in Annex II to that Regulation.

(20)

Regulation (EC) No 1223/2009 should therefore be amended accordingly.

(21)

The measures provided for in this Regulation are in accordance with the opinion of the Standing Committee on Cosmetic Products,

HAS ADOPTED THIS REGULATION:

Article 1

Annexes II, III and V to Regulation (EC) No 1223/2009 are amended in accordance with the Annex to this Regulation.

Article 2

This Regulation shall enter into force on the twentieth day following that of its publication in the Official Journal of the European Union.

This Regulation shall be binding in its entirety and directly applicable in all Member States.

Done at Brussels, 22 May 2019.

For the Commission

The President

Jean-Claude JUNCKER

(1)   OJ L 342, 22.12.2009, p. 59.

(2)  Regulation (EC) No 1272/2008 of the European Parliament and of the Council of 16 December 2008 on classification, labelling and packaging of substances and mixtures, amending and repealing Directives 67/548/EEC and 1999/45/EC, and amending Regulation (EC) No 1907/2006 (OJ L 353, 31.12.2008, p. 1).

(3)  Commission Regulation (EU) 2017/776 of 4 May 2017 amending, for the purposes of its adaptation to technical and scientific progress, Regulation (EC) No 1272/2008 of the European Parliament and of the Council on classification, labelling and packaging of substances and mixtures (OJ L 116, 5.5.2017, p. 1).

(4)  Commission Regulation (EC) No 790/2009 of 10 August 2009 amending, for the purposes of its adaptation to technical and scientific progress, Regulation (EC) No 1272/2008 of the European Parliament and of the Council on classification, labelling and packaging of substances and mixtures (OJ L 235, 5.9.2009, p. 1).

(5)  SCCS/1344/10, http://ec.europa.eu/health/scientific_committees/consumer_safety/docs/sccs_o_077.pdf.

(6)  SCCS/1360/10, http://ec.europa.eu/health/scientific_committees/consumer_safety/docs/sccs_o_053.pdf.

(7)  SCCS/1408/11, https://ec.europa.eu/health/scientific_committees/consumer_safety/docs/sccs_o_118.pdf

(8)  SCCS/1547/15, https://ec.europa.eu/health/scientific_committees/consumer_safety/docs/sccs_o_170.pdf

(9)  Commission Regulation (EU) No 605/2014 of 5 June 2014 amending, for the purposes of introducing hazard and precautionary statements in the Croatian language and its adaptation to technical and scientific progress, Regulation (EC) No 1272/2008 of the European Parliament and of the Council on classification, labelling and packaging of substances and mixtures (OJ L 167, 6.6.2014, p. 36).

(10)  SCCS/1538/14, https://ec.europa.eu/health/scientific_committees/consumer_safety/docs/sccs_o_164.pdf

(11)  SCCS/1345/10, https://ec.europa.eu/health/scientific_committees/consumer_safety/docs/sccs_o_031.pdf

(12)  Commission Regulation (EU) No 618/2012 of 10 July 2012 amending, for the purposes of its adaptation to technical and scientific progress, Regulation (EC) No 1272/2008 of the European Parliament and of the Council on classification, labelling and packaging of substances and mixtures (OJ L 179, 11.7.2012, p. 3).

(13)  SCCS/1528/14, http://ec.europa.eu/health/scientific_committees/consumer_safety/docs/sccs_o_149.pdf

(14)  SCCS/1461/12, https://ec.europa.eu/health/scientific_committees/consumer_safety/docs/sccs_o_083.pdf

(15)  Commission Regulation (EU) No 944/2013 of 2 October 2013 amending, for the purposes of its adaptation to technical and scientific progress, Regulation (EC) No 1272/2008 of the European Parliament and of the Council on classification, labelling and packaging of substances and mixtures (OJ L 261, 3.10.2013, p. 5).

(16)  SCCS/1535/14, https://ec.europa.eu/health/scientific_committees/consumer_safety/docs/sccs_o_157.pdf

(17)  SCCS/1581/16, https://ec.europa.eu/health/sites/health/files/scientific_committees/consumer_safety/docs/sccs_o_204.pdf

(18)  SCCS/1249/09, https://ec.europa.eu/health/scientific_committees/consumer_safety/docs/sccs_o_027.pdf

(19)  SCCS/1523/13, https://ec.europa.eu/health/scientific_committees/consumer_safety/docs/sccs_o_146.pdf

(20)  SCCS/1483/12, https://ec.europa.eu/health/scientific_committees/consumer_safety/docs/sccs_o_097.pdf

ANNEX

(1)   

Annex II is amended as follows:

(a)

the following entries are added:

Reference number

Substance identification

Chemical name/INN

CAS number

EC number

a

b

c

d

‘1385

Cis-1-(3-chloroallyl)-3,5,7- triaza-1-azoniaadamantane chloride (cis-CTAC)

51229-78-8

426-020-3

1386

Cis-1-(3-chlorallyl)-3,5,7-triaza-1-azoniaadamantane chloride (cis-CTAC), quaternium-15

51229-78-8

426-020-3

1387

2-Chloracetamide

79-07-2

201-174-2

1388

Octamethylcyclotetrasiloxane

556-67-2

209-136-7

1389

Dichloromethane; methylene chloride

75-09-2

200-838-9

1390

2,2′-((3,3′,5,5′-Tetramethyl-(1,1′-biphenyl)-4,4′-diyl)-bis(oxymethylene))-bis-oxirane

85954-11-6

413-900-7

1391

Acetaldehyde; ethanal

75-07-0

200-836-8

1392

1-Cyclopropyl-6,7-difluoro-1,4-dihydro-4-oxoquinoline-3-carboxylic acid

93107-30-3

413-760-7

1393

N-Methyl-2-pyrrolidone; 1-methyl-2-pyrrolidone

872-50-4

212-828-1

1394

Diboron trioxide; boric oxide

1303-86-2

215-125-8

1395

Boric acid [1]

Boric acid [2]

10043-35-3 [1]

11113-50-1 [2]

233-139-2 [1]

234-343-4 [2]

1396

Borates, tetraborates, octaborates and boric acid salts and esters, including:

 

 

Disodium octaborate tetrahydrate [1]

12280-03-4 [1]

234-541-0 [1]

2-Aminoethanol, monoester with boric acid [2]

10377-81-8 [2]

233-829-3 [2]

2-Hydroxypropyl ammonium dihydrogen orthoborate [3]

68003-13-4 [3]

268-109-8 [3]

Potassium borate, boric acid potassium salt [4]

12712-38-8 [4]

603-184-6 [4]

Trioctyldodecyl borate [5]

[5]

— [5]

Zinc borate [6]

1332-07-6 [6]

215-566-6 [6]

Sodium borate, disodium tetraborate anhydrous; boric acid, sodium salt [7]

1330-43-4 [7]

215-540-4 [7]

Tetraboron disodium heptaoxide, hydrate [8]

12267-73-1 [8]

235-541-3 [8]

Orthoboric acid, sodium salt [9]

13840-56-7 [9]

237-560-2 [9]

Disodium tetraborate decahydrate; borax decahydrate [10]

1303-96-4 [10]

215-540-4 [10]

Disodium tetraborate pentahydrate; borax pentahydrate [11]

12179-04-3 [11]

215-540-4 [11]

1397

Sodium perborate [1]

Sodium peroxometaborate; sodium peroxoborate [2]

15120-21-5 [1]

239-172-9 [1]

7632-04-4 [2]

10332-33-9 [2]

10486-00-7[2]

231-556-4 [2]

1398

Perboric acid (H3BO2(O2)), monosodium salt trihydrate [1]

13517-20-9 [1]

239-172-9 [1]

Perboric acid, sodium salt, tetrahydrate [2]

37244-98-7 [2]

234-390-0 [2]

Perboric acid (HBO(O2)), sodium salt, tetrahydrate sodium peroxoborate hexahydrate [3]

10486-00-7 [3]

231-556-4 [3]

1399

Perboric acid, sodium salt [1]

11138-47-9 [1]

234-390-0 [1]

Perboric acid, sodium salt, monohydrate [2]

12040-72-1 [2]

234-390-0 [2]

Perboric acid (HBO(O2)), sodium salt, monohydrate [3]

10332-33-9 [3]

231-556-4 [3]

1400

Dibutyltin hydrogen borate

75113-37-0

401-040-5

1401

Nickel bis(tetrafluoroborate)

14708-14-6

238-753-4

1402

Mancozeb (ISO); manganese ethylenebis(dithiocarbamate) (polymeric) complex with zinc salt

8018-01-7

616-995-5

1403

Maneb (ISO); manganese ethylenebis(dithiocarbamate) (polymeric)

12427-38-2

235-654-8

1404

Benfuracarb (ISO); ethyl N-[2,3-dihydro-2,2-dimethylbenzofuran-7-yloxycarbonyl(methyl)aminothio]-N-isopropyl- β-alaninate

82560-54-1

617-356-3

1405

O-Isobutyl-N-ethoxy carbonylthiocarbamate

103122-66-3

434-350-4

1406

Chlorpropham (ISO); isopropyl 3-chlorocarbanilate

101-21-3

202-925-7

1407

O-Hexyl-N-ethoxycarbonylthiocarbamate

109202-58-6

432-750-3

1408

Hydroxylammonium nitrate

13465-08-2

236-691-2

1409

(4-Ethoxyphenyl)(3-(4-fluoro-3-phenoxyphenyl)propyl)dimethylsilane

105024-66-6

405-020-7

1410

Phoxim (ISO); α-(diethoxy-phosphinothioylimino) phenylacetonitrile

14816-18-3

238-887-3

1411

Glufosinate ammonium (ISO); ammonium 2-amino-4-(hydroxymethylphosphinyl)butyrate

77182-82-2

278-636-5

1412

Reaction mass of: dimethyl (2-(hydroxymethylcarbamoyl)ethyl)phosphonate; diethyl (2-(hydroxymethylcarbamoyl)ethyl)phosphonate; methyl ethyl (2-(hydroxymethylcarbamoyl)ethyl)phosphonate

—

435-960-3

1413

(4-Phenylbutyl)phosphinic acid

86552-32-1

420-450-5

1414

Reaction mass of: 4,7-bis(mercaptomethyl)-3,6,9-trithia-1,11-undecanedithiol; 4,8-bis(mercaptomethyl)-3,6,9-trithia-1,11-undecanedithiol; 5,7-bis(mercaptomethyl)-3,6,9-trithia-1,11-undecanedithiol

170016-25-8

427-050-1

1415

Potassium titanium oxide (K2Ti6O13)

12056-51-8

432-240-0

1416

Cobalt di(acetate)

71-48-7

200-755-8

1417

Cobalt dinitrate

10141-05-6

233-402-1

1418

Cobalt carbonate

513-79-1

208-169-4

1419

Nickel dichloride

7718-54-9

231-743-0

1420

Nickel dinitrate [1]

13138-45-9 [1]

236-068-5 [1]

Nitric acid, nickel salt [2]

14216-75-2 [2]

238-076-4 [2]

1421

Nickel matte

69012-50-6

273-749-6

1422

Slimes and sludges, copper electrolytic refining, decopperised, nickel sulfate

92129-57-2

295-859-3

1423

Slimes and sludges, copper electrolyte refining, decopperised

94551-87-8

305-433-1

1424

Nickel diperchlorate; perchloric acid, nickel(II) salt

13637-71-3

237-124-1

1425

Nickel dipotassium bis(sulfate) [1]

13842-46-1 [1]

237-563-9 [1]

Diammonium nickel bis(sulfate) [2]

15699-18-0 [2]

239-793-2 [2]

1426

Nickel bis(sulfamidate); nickel sulfamate

13770-89-3

237-396-1

1427

Nickel bis(tetrafluoroborate)

14708-14-6

238-753-4

1428

Nickel diformate [1]

3349-06-2 [1]

222-101-0 [1]

Formic acid, nickel salt [2]

15843-02-4 [2]

239-946-6 [2]

Formic acid, copper nickel salt [3]

68134-59-8 [3]

268-755-0 [3]

1429

Nickel di(acetate) [1]

373-02-4 [1]

206-761-7 [1]

Nickel acetate [2]

14998-37-9 [2]

239-086-1 [2]

1430

Nickel dibenzoate

553-71-9

209-046-8

1431

Nickel bis(4-cyclohexylbutyrate)

3906-55-6

223-463-2

1432

Nickel(II) stearate; nickel(II) octadecanoate

2223-95-2

218-744-1

1433

Nickel dilactate

16039-61-5

—

1434

Nickel(II) octanoate

4995-91-9

225-656-7

1435

Nickel difluoride [1]

10028-18-9 [1]

233-071-3 [1]

Nickel dibromide [2]

13462-88-9 [2]

236-665-0 [2]

Nickel diiodide [3]

13462-90-3 [3]

236-666-6 [3]

Nickel potassium fluoride [4]

11132-10-8 [4]

— [4]

1436

Nickel hexafluorosilicate

26043-11-8

247-430-7

1437

Nickel selenate

15060-62-5

239-125-2

1438

Nickel hydrogen phosphate [1]

14332-34-4 [1]

238-278-2 [1]

Nickel bis(dihydrogen phosphate) [2]

18718-11-1 [2]

242-522-3 [2]

Trinickel bis(orthophosphate) [3]

10381-36-9 [3]

233-844-5 [3]

Dinickel diphosphate [4]

14448-18-1 [4]

238-426-6 [4]

Nickel bis(phosphinate) [5]

14507-36-9 [5]

238-511-8 [5]

Nickel phosphinate [6]

36026-88-7 [6]

252-840-4 [6]

Phosphoric acid, calcium nickel salt [7]

17169-61-8 [7]

— [7]

Diphosphoric acid, nickel(II) salt [8]

19372-20-4 [8]

— [8]

1439

Diammonium nickel hexacyanoferrate

74195-78-1

—

1440

Nickel dicyanide

557-19-7

209-160-8

1441

Nickel chromate

14721-18-7

238-766-5

1442

Nickel(II) silicate [1]

21784-78-1 [1]

244-578-4 [1]

Dinickel orthosilicate [2]

13775-54-7 [2]

237-411-1 [2]

Nickel silicate (3:4) [3]

31748-25-1 [3]

250-788-7 [3]

Silicic acid, nickel salt [4]

37321-15-6 [4]

253-461-7 [4]

Trihydrogen hydroxybis[orthosilicato(4-)]trinickelate(3-) [5]

12519-85-6 [5]

235-688-3 [5]

1443

Dinickel hexacyanoferrate

14874-78-3

238-946-3

1444

Trinickel bis(arsenate); nickel(II) arsenate

13477-70-8

236-771-7

1445

Nickel oxalate [1]

547-67-1 [1]

208-933-7 [1]

Oxalic acid, nickel salt [2]

20543-06-0 [2]

243-867-2 [2]

1446

Nickel telluride

12142-88-0

235-260-6

1447

Trinickel tetrasulfide

12137-12-1

—

1448

Trinickel bis(arsenite)

74646-29-0

—

1449

Cobalt nickel gray periclase; C.I. Pigment Black 25; C.I. 77332 [1]

68186-89-0 [1]

269-051-6 [1]

Cobalt nickel dioxide [2]

58591-45-0 [2]

261-346-8 [2]

Cobalt nickel oxide [3]

12737-30-3 [3]

620-395-9 [3]

1450

Nickel tin trioxide; nickel stannate

12035-38-0

234-824-9

1451

Nickel triuranium decaoxide

15780-33-3

239-876-6

1452

Nickel dithiocyanate

13689-92-4

237-205-1

1453

Nickel dichromate

15586-38-6

239-646-5

1454

Nickel(II) selenite

10101-96-9

233-263-7

1455

Nickel selenide

1314-05-2

215-216-2

1456

Silicic acid, lead nickel salt

68130-19-8

—

1457

Nickel diarsenide [1]

12068-61-0 [1]

235-103-1 [1]

Nickel arsenide [2]

27016-75-7 [2]

248-169-1 [2]

1458

Nickel barium titanium primrose priderite; C.I. Pigment Yellow 157; C.I. 77900

68610-24-2

271-853-6

1459

Nickel dichlorate [1]

67952-43-6 [1]

267-897-0 [1]

Nickel dibromate [2]

14550-87-9 [2]

238-596-1 [2]

Ethyl hydrogen sulfate, nickel(II) salt [3]

71720-48-4 [3]

275-897-7 [3]

1460

Nickel(II) trifluoroacetate [1]

16083-14-0 [1]

240-235-8 [1]

Nickel(II) propionate [2]

3349-08-4 [2]

222-102-6 [2]

Nickel bis(benzenesulfonate) [3]

39819-65-3 [3]

254-642-3 [3]

Nickel(II) hydrogen citrate [4]

18721-51-2 [4]

242-533-3 [4]

Citric acid, ammonium nickel salt [5]

18283-82-4 [5]

242-161-1 [5]

Citric acid, nickel salt [6]

22605-92-1 [6]

245-119-0 [6]

Nickel bis(2-ethylhexanoate) [7]

4454-16-4 [7]

224-699-9 [7]

2-Ethylhexanoic acid, nickel salt [8]

7580-31-6 [8]

231-480-1 [8]

Dimethylhexanoic acid, nickel salt [9]

93983-68-7 [9]

301-323-2 [9]

Nickel(II) isooctanoate [10]

29317-63-3 [10]

249-555-2 [10]

Nickel isooctanoate [11]

27637-46-3 [11]

248-585-3 [11]

Nickel bis(isononanoate) [12]

84852-37-9 [12]

284-349-6 [12]

Nickel(II) neononanoate [13]

93920-10-6 [13]

300-094-6 [13]

Nickel(II) isodecanoate [14]

85508-43-6 [14]

287-468-1 [14]

Nickel(II) neodecanoate [15]

85508-44-7 [15]

287-469-7 [15]

Neodecanoic acid, nickel salt [16]

51818-56-5 [16]

257-447-1 [16]

Nickel(II) neoundecanoate [17]

93920-09-3 [17]

300-093-0 [17]

Bis(d.-gluconato-O 1,O 2)nickel [18]

71957-07-8 [18]

276-205-6 [18]

Nickel 3,5-bis(tert-butyl)-4-hydroxybenzoate (1:2) [19]

52625-25-9 [19]

258-051-1 [19]

Nickel(II) palmitate [20]

13654-40-5 [20]

237-138-8 [20]

(2-Ethylhexanoato-O)(isononanoato-O)nickel [21]

85508-45-8 [21]

287-470-2 [21]

(Isononanoato-O)(isooctanoato-O)nickel [22]

85508-46-9 [22]

287-471-8 [22]

(Isooctanoato-O)(neodecanoato-O)nickel [23]

84852-35-7 [23]

284-347-5 [23]

(2-Ethylhexanoato-O)(isodecanoato-O)nickel [24]

84852-39-1 [24]

284-351-7 [24]

(2-Ethylhexanoato-O)(neodecanoato-O)nickel [25]

85135-77-9 [25]

285-698-7 [25]

(Isodecanoato-O)(isooctanoato-O)nickel [26]

85166-19-4 [26]

285-909-2 [26]

(Isodecanoato-O)(isononanoato-O)nickel [27]

84852-36-8 [27]

284-348-0 [27]

(Isononanoato-O)(neodecanoato-O)nickel [28]

85551-28-6 [28]

287-592-6 [28]

Fatty acids, C6-19-branched, nickel salts [29]

91697-41-5 [29]

294-302-1 [29]

Fatty acids, C8-18 and C18-unsaturated, nickel salts [30]

84776-45-4 [30]

283-972-0 [30]

2,7-Naphthalenedisulfonic acid, nickel(II) salt [31]

72319-19-8 [31]

[31]

1461

Nickel(II) sulfite [1]

7757-95-1 [1]

231-827-7 [1]

Nickel tellurium trioxide [2]

15851-52-2 [2]

239-967-0 [2]

Nickel tellurium tetraoxide [3]

15852-21-8 [3]

239-974-9 [3]

Molybdenum nickel hydroxide oxide phosphate [4]

68130-36-9 [4]

268-585-7 [4]

1462

Nickel boride (NiB) [1]

12007-00-0 [1]

234-493-0 [1]

Dinickel boride [2]

12007-01-1 [2]

234-494-6 [2]

Trinickel boride [3]

12007-02-2 [3]

234-495-1 [3]

Nickel boride [4]

12619-90-8 [4]

235-723-2 [4]

Dinickel silicide [5]

12059-14-2 [5]

235-033-1 [5]

Nickel disilicide [6]

12201-89-7 [6]

235-379-3 [6]

Dinickel phosphide [7]

12035-64-2 [7]

234-828-0 [7]

Nickel boron phosphide [8]

65229-23-4 [8]

— [8]

1463

Dialuminium nickel tetraoxide [1]

12004-35-2 [1]

234-454-8 [1]

Nickel titanium trioxide [2]

12035-39-1 [2]

234-825-4 [2]

Nickel titanium oxide [3]

12653-76-8 [3]

235-752-0 [3]

Nickel divanadium hexaoxide [4]

52502-12-2 [4]

257-970-5 [4]

Cobalt dimolybdenum nickel octaoxide [5]

68016-03-5 [5]

268-169-5 [5]

Nickel zirkonium trioxide [6]

70692-93-2 [6]

274-755-1 [6]

Molybdenum nickel tetraoxide [7]

14177-55-0 [7]

238-034-5 [7]

Nickel tungsten tetraoxide [8]

14177-51-6 [8]

238-032-4 [8]

Olivine, nickel green [9]

68515-84-4 [9]

271-112-7 [9]

Lithium nickel dioxide [10]

12031-65-1 [10]

620-400-4 [10]

Molybdenum nickel oxide [11]

12673-58-4 [11]

— [11]

1464

Cobalt lithium nickel oxide

—

442-750-5

1465

Molybdenum trioxide

1313-27-5

215-204-7

1466

Dibutyltin dichloride; (DBTC)

683-18-1

211-670-0

1467

4,4′-Bis(N-carbamoyl-4-methylbenzenesulfonamide)diphenylmethane

151882-81-4

418-770-5

1468

Furfuryl alcohol

98-00-0

202-626-1

1469

1,2-Epoxy-4-epoxyethylcyclohexane; 4-vinylcyclohexene diepoxide

106-87-6

203-437-7

1470

6-Glycidyloxynapht-1-yl oxymethyloxirane

27610-48-6

429-960-2

1471

2-(2-Aminoethylamino)ethanol; (AEEA)

111-41-1

203-867-5

1472

1,2-Diethoxyethane

629-14-1

211-076-1

1473

2,3-Epoxypropyltrimethylammonium chloride; glycidyl trimethylammonium chloride

3033-77-0

221-221-0

1474

1-(2-Amino-5-chlorophenyl)-2,2,2-trifluoro-1,1-ethanediol, hydrochloride

214353-17-0

433-580-2

1475

(E)-3-[1-[4-[2-(Dimethylamino)ethoxy]phenyl]-2-phenylbut-1-enyl]phenol

82413-20-5

428-010-4

1476

4,4′-(1,3-Phenylene-bis(1-methylethylidene))bis-phenol

13595-25-0

428-970-4

1477

2-Chloro-6-fluoro-phenol

2040-90-6

433-890-8

1478

2-Methyl-5-tert-butylthiophenol

—

444-970-7

1479

2-Butyryl-3-hydroxy-5-thiocyclohexan-3-yl-cyclohex-2-en-1-one

94723-86-1

425-150-8

1480

Profoxydim (ISO); 2-{(EZ)-1-[(2RS)-2-(4-chlorophenoxy)propoxyimino]butyl}-3-hydroxy-5-(thian-3-yl)cyclohex-2-en-1-one

139001-49-3

604-105-8

1481

Tepraloxydim (ISO); (RS)-(EZ)-2-{1-[(2E)-3-chloroallyloxyimino]propyl}-3-hydroxy-5-perhydropyran-4-ylcyclohex-2-en-1-one

149979-41-9

604-715-4

1482

Cyclic 3-(1,2-ethanediylacetale)-estra-5(10),9(11)-diene-3,17-dione

5571-36-8

427-230-8

1483

Androsta-1,4,9(11)-triene-3,17-dione

15375-21-0

433-560-3

1484

Reaction mass of: Ca salicylates (branched C10-14 and C18-30 alkylated); Ca phenates (branched C10-14 and C18-30 alkylated); Ca sulfurised phenates (branched C10-14 and C18-30 alkylated)

—

415-930-6

1485

1,2-Benzenedicarboxylic acid; di-C6-8-branched alkylesters, C7-rich

71888-89-6

276-158-1

1486

Reaction mass of: diester of 4,4′-methylenebis[2-(2-hydroxy-5-methylbenzyl)-3,6-dimethylphenol] and 6-diazo-5,6-dihydro-5-oxonaphthalene-1-sulfonic acid (1:2); triester of 4,4′-methylenebis[2-(2-hydroxy-5-methylbenzyl)-3,6-dimethylphenol] and 6-diazo-5,6-dihydro-5-oxonaphthalene-1-sulfonic acid (1:3)

—

427-140-9

1487

Diammonium 1-hydroxy-2-(4-(4-carboxyphenylazo)-2,5-dimethoxyphenylazo)-7-amino-3-naphthalenesulfonate

150202-11-2

422-670-7

1488

3-Oxoandrost-4-ene-17-β-carboxylic acid

302-97-6

414-990-0

1489

(Z)-2-Methoxymino-2-[2-(tritylamino)thiazol-4-yl]acetic acid

64485-90-1

431-520-1

1490

Trisodium nitrilotriacetate

5064-31-3

225-768-6

1491

2-Ethylhexyl-2-ethylhexanoate

7425-14-1

231-057-1

1492

Diisobutyl phthalate

84-69-5

201-553-2

1493

Perfluorooctane sulfonic acid; heptadecafluorooctane-1-sulfonic acid [1]

1763-23-1 [1]

217-179-8 [1]

Potassium perfluorooctanesulfonate; potassium heptadecafluorooctane-1-sulfonate [2]

2795-39-3 [2]

220-527-1 [2]

Diethanolamine perfluorooctane sulfonate [3]

70225-14-8 [3]

274-460-8 [3]

Ammonium perfluorooctane sulfonate; ammonium heptadecafluorooctanesulfonate [4]

29081-56-9 [4]

249-415-0 [4]

Lithium perfluorooctane sulfonate; lithium heptadecafluorooctanesulfonate [5]

29457-72-5 [5]

249-644-6 [5]

1494

Ethyl 1-(2,4-dichlorophenyl)5-(trichloromethyl)-1H-1,2,4-triazole-3-carboxylate

103112-35-2

401-290-5

1495

1-Bromo-2-methylpropyl propionate

158894-67-8

422-900-6

1496

Chloro-1-ethylcyclohexyl carbonate

99464-83-2

444-950-8

1497

6,6′-Bis(diazo-5,5′,6,6′-tetrahydro-5,5′-dioxo)[methylene-bis(5-(6-diazo-5,6-dihydro-5-oxo-1-naphthylsulphonyloxy)-6-methyl-2-phenylene]di(naphthalene-1-sulfonate)

—

441-550-5

1498

Trifluralin (ISO); α,α,α-trifluoro-2,6-dinitro-N,N-dipropyl-p-toluidine; 2,6-dinitro-N,N-dipropyl-4-trifluoromethylaniline; N,N-dipropyl-2,6-dinitro-4-trifluoromethylaniline

1582-09-8

216-428-8

1499

4-Mesyl-2-nitrotoluene

1671-49-4

430-550-0

1500

Triammonium 4-[4-[7-(4-carboxylatoanilino)-1-hydroxy-3-sulfonato-2-naphthylazo]-2,5-dimethoxyphenylazo]benzoate

221354-37-6

432-270-4

1501

Reaction mass of: triammonium 6-amino-3-((2,5-diethoxy-4-(3-phosphonophenyl)azo)phenyl)azo-4-hydroxy-2-naphthalenesulfonate; diammonium 3-((4-((7-amino-1-hydroxy-3-sulfo-naphthalen-2-yl)azo)-2,5-diethoxyphenyl)azo)benzoate

163879-69-4

438-310-7

1502

N,N′-Diacetylbenzidine

613-35-4

210-338-2

1503

Cyclohexylamine

108-91-8

203-629-0

1504

Piperazine

110-85-0

203-808-3

1505

Hydroxylamine

7803-49-8

232-259-2

1506

Hydroxylammonium chloride; hydroxylamine hydrochloride [1]

5470-11-1 [1]

226-798-2 [1]

Bis(hydroxylammonium) sulfate; hydroxylamine sulfate (2:1) [2]

10039-54-0 [2]

233-118-8 [2]

1507

Methyl-phenylene diamine; diaminotoluene

—

—

1508

Mepanipyrim; 4-methyl-N-phenyl-6-(1-propynyl)-2-pyrimidinamine

110235-47-7

600-951-7

1509

Hydroxylammonium hydrogensulfate; hydroxylamine sulfate(1:1) [1]

10046-00-1 [1]

233-154-4 [1]

Hydroxylamine phosphate [2]

20845-01-6 [2]

244-077-0 [2]

Hydroxylamine dihydrogenphosphate [3]

19098-16-9 [3]

242-818-2 [3]

Hydroxylamine 4-methylbenzenesulfonate [4]

53933-48-5 [4]

258-872-5 [4]

1510

(3-Chloro-2-hydroxypropyl) trimethylammonium chloride

3327-22-8

222-048-3

1511

Biphenyl-3,3′,4,4′-tetrayltetraamine; diaminobenzidine

91-95-2

202-110-6

1512

Piperazine hydrochloride [1]

6094-40-2 [1]

228-042-7 [1]

Piperazine dihydrochloride [2]

142-64-3 [2]

205-551-2 [2]

Piperazine phosphate [3]

1951-97-9 [3]

217-775-8 [3]

1513

3-(Piperazin-1-yl)-benzo[d]isothiazole hydrochloride

87691-88-1

421-310-6

1514

2-Ethylphenylhydrazine hydrochloride

19398-06-2

421-460-2

1515

(2-Chloroethyl)(3-hydroxypropyl)ammonium chloride

40722-80-3

429-740-6

1516

4-[(3-Chlorophenyl)(1H-imidazol-1-yl)methyl]-1,2-benzenediamine dihydrochloride

159939-85-2

425-030-5

1517

Chloro-N,N-dimethylformiminium chloride

3724-43-4

425-970-6

1518

7-Methoxy-6-(3-morpholin-4-yl-propoxy)-3H-quinazolin-4-one

199327-61-2

429-400-7

1519

Reaction products of diisopropanolamine with formaldehyde (1:4)

220444-73-5

432-440-8

1520

3-Chloro-4-(3-fluorobenzyloxy)aniline

202197-26-0

445-590-4

1521

Ethidium bromide; 3,8-diamino-1-ethyl-6-phenylphenantridinium bromide

1239-45-8

214-984-6

1522

(R,S)-2-Amino-3,3-dimethylbutane amide

144177-62-8

447-860-7

1523

3-Amino-9-ethyl carbazole; 9-ethylcarbazol-3-ylamine

132-32-1

205-057-7

1524

(6R-trans)-1-((7-Ammonio-2-carboxylato-8-oxo-5-thia-1-azabicyclo-[4.2.0]oct-2-en-3-yl)methyl)pyridinium iodide

100988-63-4

423-260-0

1525

Forchlorfenuron (ISO); 1-(2-chloro-4-pyridyl)-3-phenylurea

68157-60-8

614-346-0

1526

Tetrahydro-1,3-dimethyl-1H-pyrimidin-2-one; dimethyl propyleneurea

7226-23-5

230-625-6

1527

Quinoline

91-22-5

202-051-6

1528

Ketoconazole; 1-[4-[4-[[(2SR,4RS)-2-(2,4-dichlorophenyl)-2-(imidazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]piperazin-1-yl]ethanone

65277-42-1

265-667-4

1529

Metconazole (ISO); (1RS,5RS;1RS,5SR)-5-(4-chlorobenzyl)-2,2-dimethyl-1-(1H-1,2,4-triazol-1-ylmethyl)cyclopentanol

125116-23-6

603-031-3

1530

Potassium 1-methyl-3-morpholinocarbonyl-4-[3-(1-methyl-3-morpholinocarbonyl-5-oxo-2-pyrazolin-4-ylidene)-1-propenyl]pyrazole-5-olate

183196-57-8

418-260-2

1531

N,N′,N′-Tris(2-methyl-2,3-epoxypropyl)-perhydro-2,4,6-oxo-1,3,5-triazine

26157-73-3

435-010-8

1532

Trimethylopropane tri(3-aziridinylpropanoate); (TAZ)

52234-82-9

257-765-0

1533

4,4′-Methylenediphenyl diisocyanate; diphenylmethane-4,4′-diisocyanate [1]

101-68-8 [1]

202-966-0 [1]

2,2′-Methylenediphenyl diisocyanate; diphenylmethane-2,2′-diisocyanate [2]

2536-05-2 [2]

219-799-4 [2]

o-(p-Isocyanatobenzyl)phenyl isocyanate; diphenylmethane-2,4′-diisocyanate [3]

5873-54-1 [3]

227-534-9 [3]

Methylenediphenyl diisocyanate [4]

26447-40-5 [4]

247-714-0 [4]

1534

Cinidon ethyl (ISO); ethyl (Z)-2-chloro-3-[2-chloro-5-(cyclohex-1-ene-1,2-dicarboximido)phenyl]acrylate

142891-20-1

604-318-6

1535

N-[6,9-Dihydro-9-[[2-hydroxy-1-(hydroxymethyl)ethoxy]methyl]-6-oxo-1H-purin-2-yl]acetamide

84245-12-5

424-550-1

1536

Dimoxystrobin (ISO); (E)-2-(methoxyimino)-N-methyl-2-[α-(2,5-xylyloxy)-o-tolyl]acetamide

149961-52-4

604-712-8

1537

N,N-(Dimethylamino)thioacetamide hydrochloride

27366-72-9

435-470-1

1538

Reaction mass of: 2,2′-[(3,3′-dichloro[1,1′-biphenyl]-4,4′-diyl)bis(azo)]bis[N-(2,4-dimethylphenyl)]-3-oxo-butanamide; 2-[[3,3′-dichloro-4′-[[1[[(2,4-dimethylphenyl)amino]carbonyl]-2-oxopropyl]azo][1,1′-biphenyl]-4-yl]azo]-N-(2-methylphenyl)-3-oxo-butanamide; 2-[[3,3′-dichloro-4′-[[1[[(2,4-dimethylphenyl)amino]carbonyl]-2-oxopropyl]azo][1,1′- biphenyl]-4-yl]azo]-N-(2-carboxylphenyl)-3- oxo-butanamide

 

434-330-5

1539

Petroleum, coal, tar and natural gas and their derivatives generated using distillation and/or other processing methods if they contain ≥ 0,1 % w/w benzene

85536-20-5

85536-19-2

90641-12-6

90989-38-1

91995-20-9

92062-36-7

91995-61-8

101316-63-6

93821-38-6

90641-02-4

101316-62-5

90641-03-5

65996-79-4

101794-90-5

90640-87-2

84650-03-3

65996-82-9

90641-01-3

65996-87-4

90640-99-6

68391-11-7

92062-33-4

91082-52-9

68937-63-3

92062-28-7

92062-27-6

91082-53-0

91995-31-2

91995-35-6

91995-66-3

122070-79-5

122070-80-8

65996-78-3

94114-52-0

94114-53-1

94114-54-2

94114-56-4

94114-57-5

90641-11-5

8006-61-9

8030-30-6

8032-32-4

64741-41-9

64741-42-0

64741-46-4

64742-89-8

68410-05-9

68514-15-8

68606-11-1

68783-12-0

68921-08-4

101631-20-3

64741-64-6

64741-65-7

64741-66-8

64741-70-4

64741-84-0

64741-92-0

68410-71-9

68425-35-4

68527-27-5

91995-53-8

92045-49-3

92045-55-1

92045-58-4

92045-64-2

101316-67-0

64741-54-4

64741-55-5

68476-46-0

68783-09-5

91995-50-5

92045-50-6

92045-59-5

92128-94-4

101794-97-2

101896-28-0

64741-63-5

64741-68-0

68475-79-6

68476-47-1

68478-15-9

68513-03-1

68513-63-3

68514-79-4

68919-37-9

68955-35-1

85116-58-1

91995-18-5

93571-75-6

93572-29-3

93572-35-1

93572-36-2

64741-74-8

64741-83-9

67891-79-6

67891-80-9

68425-29-6

68475-70-7

68603-00-9

68603-01-0

68603-03-2

68955-29-3

92045-65-3

64742-48-9

64742-49-0

64742-73-0

68410-96-8

68410-97-9

68410-98-0

68512-78-7

85116-60-5

85116-61-6

92045-51-7

92045-52-8

92045-57-3

92045-61-9

92062-15-2

93165-55-0

93763-33-8

93763-34-9

64741-47-5

64741-48-6

64741-69-1

64741-78-2

64741-87-3

64742-15-0

64742-22-9

64742-23-0

64742-66-1

64742-83-2

64742-95-6

68131-49-7

68477-34-9

68477-50-9

68477-53-2

68477-55-4

68477-61-2

68477-89-4

68478-12-6

68478-16-0

68513-02-0

68516-20-1

68527-21-9

68527-22-0

68527-23-1

68527-26-4

68603-08-7

68606-10-0

68783-66-4

68919-39-1

68921-09-5

85116-59-2

86290-81-5

90989-42-7

91995-38-9

91995-41-4

91995-68-5

92045-53-9

92045-60-8

92045-62-0

92045-63-1

92201-97-3

93165-19-6

94114-03-1

95009-23-7

97926-43-7

98219-46-6

98219-47-7

101316-56-7

101316-66-9

101316-76-1

101795-01-1

102110-14-5

68476-50-6

68476-55-1

90989-39-2

287-502-5

287-500-4

292-636-2

292-694-9

295-281-1

295-551-9

295-323-9

309-868-8

298-725-2

292-625-2

309-867-2

292-626-8

266-013-0

309-971-8

292-609-5

283-483-2

266-016-7

292-624-7

266-021-4

292-622-6

269-929-9

295-548-2

293-766-2

273-077-3

295-543-5

295-541-4

293-767-8

295-292-1

295-295-8

295-329-1

310-170-0

310-171-6

266-012-5

302-688-0

302-689-6

302-690-1

302-692-2

302-693-8

292-635-7

232-349-1

232-443-2

232-453-7

265-041-0

265-042-6

265-046-8

265-192-2

270-077-5

271-025-4

271-727-0

272-186-3

272-931-2

309-945-6

265-066-7

265-067-2

265-068-8

265-073-5

265-086-6

265-095-5

270-088-5

270-349-3

271-267-0

295-315-5

295-430-0

295-436-3

295-440-5

295-446-8

309-871-4

265-055-7

265-056-2

270-686-6

272-185-8

295-311-3

295-431-6

295-441-0

295-794-0

309-974-4

309-987-5

265-065-1

265-070-9

270-660-4

270-687-1

270-794-3

270-993-5

271-008-1

271-058-4

272-895-8

273-271-8

285-509-8

295-279-0

297-401-8

297-458-9

297-465-7

297-466-2

265-075-6

265-085-0

267-563-4

267-565-5

270-344-6

270-658-3

271-631-9

271-632-4

271-634-5

273-266-0

295-447-3

265-150-3

265-151-9

265-178-6

270-092-7

270-093-2

270-094-8

270-988-8

285-511-9

285-512-4

295-432-1

295-433-7

295-438-4

295-443-1

295-529-9

296-942-7

297-852-0

297-853-6

265-047-3

265-048-9

265-071-4

265-079-8

265-089-2

265-115-2

265-122-0

265-123-6

265-170-2

265-187-5

265-199-0

268-618-5

270-725-7

270-735-1

270-736-7

270-738-8

270-741-4

270-771-8

270-791-7

270-795-9

270-991-4

271-138-9

271-262-3

271-263-9

271-264-4

271-266-5

271-635-0

271-726-5

272-206-0

272-896-3

272-932-8

285-510-3

289-220-8

292-698-0

295-298-4

295-302-4

295-331-2

295-434-2

295-442-6

295-444-7

295-445-2

296-028-8

296-903-4

302-639-3

305-750-5

308-261-5

308-713-1

308-714-7

309-862-5

309-870-9

309-879-8

309-976-5

310-012-0

270-690-8

270-695-5

292-695-4

1540

Petroleum, coal, tar and natural gas and their derivatives generated using distillation and/or other processing methods if they contain ≥ 0,005 % w/w benzo[a]pyrene

 

 

 

 

90640-85-0

92061-93-3

90640-84-9

61789-28-4

70321-79-8

122384-77-4

70321-80-1

292-606-9

295-506-3

292-605-3

263-047-8

274-565-9

310-189-4

274-566-4

1541

Petroleum, coal, tar and natural gas and their derivatives generated using distillation and/or other processing methods if they contain ≥ 0,1 % w/w benzene or if they contain ≥ 0,005 % w/w benzo[a]pyrene

 

 

 

 

85029-51-2

84650-04-4

84989-09-3

91995-49-2

121620-47-1

121620-48-2

90640-90-7

90641-04-6

101896-27-9

101794-91-6

91995-48-1

90641-05-7

84989-12-8

121620-46-0

90640-81-6

90640-82-7

92061-92-2

91995-15-2

91995-16-3

91995-17-4

101316-87-4

122384-78-5

84988-93-2

90640-88-3

65996-83-0

90640-89-4

90641-06-8

65996-85-2

101316-86-3

92062-22-1

96690-55-0

84989-04-8

84989-05-9

84989-06-0

84989-03-7

84989-07-1

68477-23-6

68555-24-8

91079-47-9

92062-26-5

94114-29-1

90641-00-2

68513-87-1

70321-67-4

92062-29-8

100801-63-6

100801-65-8

100801-66-9

73665-18-6

68815-21-4

65996-86-3

65996-84-1

285-076-5

283-484-8

284-898-1

295-310-8

310-166-9

310-167-4

292-612-1

292-627-3

309-985-4

309-972-3

295-309-2

292-628-9

284-901-6

310-165-3

292-603-2

292-604-8

295-505-8

295-275-9

295-276-4

295-278-5

309-889-2

310-191-5

284-881-9

292-610-0

266-017-2

292-611-6

292-629-4

266-019-3

309-888-7

295-536-7

306-251-5

284-892-9

284-893-4

284-895-5

284-891-3

284-896-0

270-713-1

271-418-0

293-435-2

295-540-9

302-662-9

292-623-1

271-020-7

274-560-1

295-544-0

309-745-9

309-748-5

309-749-0

277-567-8

272-361-4

266-020-9

266-018-8

1542

Petroleum, coal, tar and natural gas and their derivatives generated using distillation and/or other processing methods if they contain ≥ 0,1 % w/w 1,3-butadiene

 

 

 

 

68607-11-4

68783-06-2

68814-67-5

68814-90-4

68911-58-0

68911-59-1

68919-01-7

68919-02-8

68919-03-9

68919-04-0

68919-07-3

68919-08-4

68919-11-9

68919-12-0

68952-79-4

68952-80-7

68955-33-9

68989-88-8

92045-15-3

92045-16-4

92045-17-5

92045-18-6

92045-19-7

92045-20-0

68131-75-9

68307-98-2

68307-99-3

68308-00-9

68308-01-0

68308-10-1

68308-03-2

68308-04-3

68308-05-4

68308-06-5

68308-07-6

68308-09-8

68308-11-2

68308-12-3

68409-99-4

68475-57-0

68475-58-1

68475-59-2

68475-60-5

68476-26-6

68476-29-9

68476-40-4

68476-42-6

68476-49-3

68476-85-7

68476-86-8

68477-33-8

68477-35-0

68477-69-0

68477-70-3

68477-71-4

68477-72-5

68308-08-7

271-750-6

272-182-1

272-338-9

272-343-6

272-775-5

272-776-0

272-873-8

272-874-3

272-875-9

272-876-4

272-880-6

272-881-1

272-884-8

272-885-3

273-173-5

273-174-0

273-269-7

273-563-5

295-397-2

295-398-8

295-399-3

295-400-7

295-401-2

295-402-8

268-629-5

269-617-2

269-618-8

269-619-3

269-620-9

269-630-3

269-623-5

269-624-0

269-625-6

269-626-1

269-627-7

269-629-8

269-631-9

269-632-4

270-071-2

270-651-5

270-652-0

270-653-6

270-654-1

270-667-2

270-670-9

270-681-9

270-682-4

270-689-2

270-704-2

270-705-8

270-724-1

270-726-2

270-750-3

270-751-9

270-752-4

270-754-5

269-628-2

1543

Tris[2-chloro-1-(chloromethyl)ethyl] phosphate

13674-87-8

237-159-2

1544

Indium phosphide

22398-80-7

244-959-5

1545

Trixylyl phosphate

25155-23-1

246-677-8

1546

Hexabromocyclododecane [1]

25637-99-4 [1]

247-148-4 [1]

1,2,5,6,9,10-Hexabromocyclododecane [2]

3194-55-6 [2]

221-695-9 [2]

1547

Tetrahydrofuran

109-99-9

203-726-8

1548

Abamectin (combination of avermectin B1a and avermectin B1b) (ISO) [1]

71751-41-2 [1]

615-339-5 [1]

Avermectin B1a [2]

65195-55-3 [2]

265-610-3 [2]

1549

4-tert-Butylbenzoic acid

98-73-7

202-696-3

1550

Leucomalachite green; N,N,N′,N′-tetramethyl-4,4′-benzylidenedianiline

129-73-7

204-961-9

1551

Fuberidazole (ISO); 2-(2-furyl)-1H-benzimidazole

3878-19-1

223-404-0

1552

Metazachlor (ISO); 2-chloro-N-(2,6-dimethylphenyl)-N-(1H-pyrazol-1-ylmethyl)acetamide

67129-08-2

266-583-0

1553

Di-tert-butyl peroxide

110-05-4

203-733-6

1554

Trichloromethylstannane

993-16-8

213-608-8

1555

2-Ethylhexyl 10-ethyl-4-[[2-[(2-ethylhexyl)oxy]-2-oxoethyl]thio]-4-methyl-7-oxo-8-oxa-3,5-dithia-4-stannatetradecanoate

57583-34-3

260-828-5

1556

2-Ethylhexyl 10-ethyl-4,4-dioctyl-7-oxo-8-oxa-3,5-dithia-4-stannatetradecanoate

15571-58-1

239-622-4

1557

Sulcotrione (ISO); 2-[2-chloro-4-(methylsulfonyl)benzoyl]cyclohexane-1,3-dione

99105-77-8

619-394-6

1558

Bifenthrin (ISO); (2-methylbiphenyl-3-yl)methyl rel-(1R,3R)-3-[(1Z)-2-chloro-3,3,3-trifluoroprop-1-en-1-yl]-2,2-dimethylcyclopropanecarboxylate

82657-04-3

617-373-6

1559

Dihexyl phthalate

84-75-3

201-559-5

1560

Ammonium pentadecafluorooctanoate

3825-26-1

223-320-4

1561

Perfluorooctanoic acid

335-67-1

206-397-9

1562

N-Ethyl-2-pyrrolidone; 1-ethylpyrrolidin-2-one

2687-91-4

220-250-6

1563

Proquinazid (ISO); 6-iodo-2-propoxy-3-propylquinazolin-4(3H)-one

189278-12-4

606-168-7

1564

Gallium arsenide

1303-00-0

215-114-8

1565

Vinyl acetate

108-05-4

203-545-4

1566

Aclonifen (ISO); 2-chloro-6-nitro-3-phenoxyaniline

74070-46-5

277-704-1

1567

2-Ethylhexyl 10-ethyl-4,4-dimethyl-7-oxo-8-oxa-3,5-dithia-4-stannatetradecanoate

57583-35-4

260-829-0

1568

Dimethyltin dichloride

753-73-1

212-039-2

1569

4-Vinylcyclohexene

100-40-3

202-848-9

1570

Tralkoxydim (ISO); 2-(N-ethoxypropanimidoyl)-3-hydroxy-5-mesitylcyclohex-2-en-1-one

87820-88-0

618-075-9

1571

Cycloxydim (ISO); 2-(N-ethoxybutanimidoyl)-3-hydroxy-5-(tetrahydro-2H-thiopyran-3-yl)cyclohex-2-en-1-one

101205-02-1

405-230-9

1572

Fluazinam (ISO); 3-chloro-N-[3-chloro-2,6-dinitro-4-(trifluoromethyl)phenyl]-5-(trifluoromethyl)pyridin-2-amine

79622-59-6

616-712-5

1573

Penconazole (ISO); 1-[2-(2,4-dichlorophenyl)pentyl]-1H-1,2,4-triazole

66246-88-6

266-275-6

1574

Fenoxycarb (ISO); ethyl [2-(4-phenoxyphenoxy)ethyl]carbamate

72490-01-8

276-696-7

1575

Styrene

100-42-5

202-851-5

1576

Tetrahydro-2-furylmethanol; tetrahydrofurfuryl alcohol

97-99-4

202-625-6

1577

Formaldehyde

50-00-0

200-001-8

1578

Paraformaldehyde

30525-89-4

608-494-5

1579

Methanediol; methylene glycol

463-57-0

207-339-5

1580

Cymoxanil (ISO); 2-cyano-N-[(ethylamino)carbonyl]-2-(methoxyimino)acetamide

57966-95-7

261-043-0

1581

Tributyltin compounds

—

—

1582

Tembotrione (ISO); 2-{2-chloro-4-(methylsulfonyl)-3-[(2,2,2-trifluoroethoxy)methyl]benzoyl}cyclohexane-1,3-dione

335104-84-2

608-879-8

1583

1,2-Benzenedicarboxylic acid, dihexyl ester, branched and linear

68515-50-4

271-093-5

1584

Spirotetramat (ISO); (5s,8s)-3-(2,5-dimethylphenyl)-8-methoxy-2-oxo-1-azaspiro[4,5]dec-3-en-4-yl ethyl carbonate

203313-25-1

606-523-6

1585

Dodemorph acetate; 4-cyclododecyl-2,6-dimethylmorpholin-4-ium acetate

31717-87-0

250-778-2

1586

Triflusulfuron-methyl; methyl 2-({[4-(dimethylamino)-6-(2,2,2- trifluoroethoxy)-1,3,5-triazin-2- yl]carbamoyl}sulfamoyl)-3- methylbenzoate

126535-15-7

603-146-9

1587

Imazalil (ISO); 1-[2-(allyloxy)-2-(2,4-dichlorophenyl)ethyl]-1H-imidazole

35554-44-0

252-615-0

1588

Dodemorph (ISO); 4-cyclododecyl-2,6-dimethylmorpholine

1593-77-7

216-474-9

1589

Imidazole

288-32-4

206-019-2

1590

Lenacil (ISO); 3-cyclohexyl-6,7-dihydro-1H-cyclopenta[d]pyrimidine-2,4(3H,5H)-dione

2164-08-1

218-499-0

1591

Metosulam (ISO); N-(2,6-dichloro-3-methylphenyl)-5,7-dimethoxy[1,2,4]triazolo[1,5-a]pyrimidine-2-sulfonamide

139528-85-1

604-145-6

1592

2-Methyl-1-(4-methylthiophenyl)-2-morpholino-propan 1-one

71868-10-5

400-600-6

1593

2,3-Epoxypropyl methacrylate; glycidyl methacrylate

106-91-2

203-441-9

1594

Spiroxamine (ISO); 8-tert-butyl-1,4-dioxaspirol[4.5]decan-2-ylmethyl(ethyl)(propyl)amine

118134-30-8

601-505-4

1595

Cyanamide; carbanonitril

420-04-2

206-992-3

1596

Cyproconazole (ISO); (2RS,3RS;2RS,3SR)-2-(4-chlorophenyl)-3-cyclopropyl-1-(1H-1,2,4-triazol-1-yl)butan-2-ol

94361-06-5

619-020-1

1597

Silver zinc zeolite

130328-20-0

603-404-0

1598

Cadmium carbonate

513-78-0

208-168-9

1599

Cadmium hydroxide; cadmium dihydroxide

21041-95-2

244-168-5

1600

Cadmium nitrate; cadmium dinitrate

10325-94-7

233-710-6

1601

Dibutyltin dilaurate; dibutyl[bis(dodecanoyloxy)] stannane

77-58-7

201-039-8

1602

Clorofene; chlorophene; 2-benzyl-4-chlorophenol

120-32-1

204-385-8

1603

Anthraquinone

84-65-1

201-549-0

1604

Nonadecafluorodecanoic acid [1]

335-76-2 [1]

206-400-3[1]

Ammonium nonadecafluorodecanoate [2]

3108-42-7 [2]

221-470-5 [2] [3]

Sodium nonadecafluorodecanoate [3]

3830-45-3 [3]

 

1605

N,N′-Methylenedimorpholine; N,N′-methylenebismorpholine; [formaldehyde released from N,N′-Methylenebismorpholine]; [MBM]

if the maximum theoretical concentration of releasable formaldehyde, irrespective of the source, in the mixture as placed on the market is ≥ 0,1 % w/w

5625-90-1

227-062-3

1606

Reaction products of paraformaldehyde with 2-hydroxypropylamine (3:2); [formaldehyde released from 3,3′-methylenebis[5–methyloxazolidine]; [formaldehyde released from oxazolidin]; [MBO]

if the maximum theoretical concentration of releasable formaldehyde, irrespective of the source, in the mixture as placed on the market is ≥ 0,1 % w/w

—

—

1607

Reaction products of paraformaldehyde with 2-hydroxypropylamine (1:1)); [formaldehyde released from α,α,α-trimethyl-1,3,5-triazine-1,3,5(2H,4H,6H)-triethanol]; [HPT]

if the maximum theoretical concentration of releasable formaldehyde, irrespective of the source, in the mixture as placed on the market is ≥ 0,1 % w/w

—

—

1608

Methylhydrazine

60-34-4

200-471-4

1609

Triadimenol (ISO); (1RS,2RS;1RS,2SR)-1-(4-chlorophenoxy)-3,3-dimethyl-1-(1H-1,2,4-triazol-1-yl)butan-2-ol; α-tert-butyl-β-(4-chlorophenoxy)-1H-1,2,4-triazole-1-ethanol

55219-65-3

259-537-6

1610

Thiacloprid (ISO); (Z)-3-(6-chloro-3-pyridyl-methyl)-1-3-thiazolidin-2-ylidenecyanamide; {(2Z)-3-[(6-chloropyridin-3-yl)methyl]-1,3-thiazolidin-2-ylidene}cyanamide

111988-49-9

601-147-9

1611

Carbetamide (ISO); (R)-1-(ethylcarbamoyl) ethyl-carbanilate; (2R)-1-(ethylamino) -1-oxopro-pan-2-yl-phenylcarbamate

16118-49-3

240-286-6’

(b)

entry 395 is replaced by the following:

Reference number

Substance identification

Chemical name/INN

CAS number

EC number

‘395

Hydroxy-8-quinoline and its sulphate

148-24-2

134-31-6

205-711-1

205-137-1’

(2)   

Annex III is amended as follows:

(a)

entries 1a, 1b, 7, 13 and 51 are deleted;

(b)

entry 12 is replaced by the following;

Reference number

Substance identification

Restrictions

Wording of conditions of use and warnings

Chemical name/INN

Name of Common Ingredients Glossary

CAS number

EC number

Product type, body parts

Maximum concentration in ready for use preparation

Other

a

b

c

d

e

f

g

h

i

‘12

Hydrogen peroxide and other compounds or mixtures that release hydrogen peroxide, including carbamide peroxide and zinc peroxide, with the exception of the following substances in Annex II:

—

No 1397, 1398, 1399

Hydrogen peroxide

7722-84-1

231-765-0

(a)

Hair products

(a)

12 % of H2O2 (40 volumes), present or released

 

(a) (f) Wear suitable gloves

(a) (b) (c) (e)

Contains hydrogen peroxide

Avoid contact with eyes

Rinse immediately if product comes into contact with them.

(b)

Skin products

(b)

4 % of H2O2, present or released

(c)

Nail hardening products

(c)

2 % of H2O2, present or released

(d)

Oral products, including mouth rinse, tooth paste and tooth whitening or bleaching products

(d)

≤ 0,1 % of H2O2, present or released

(e)

Tooth whitening or bleaching products

(e)

> 0,1 % ≤ 6 % of H2O2, present or released

(e)

To be only sold to dental practitioners. For each cycle of use, first use by dental practitioners as defined under Directive 2005/36/EC of the European Parliament and of the Council (*1) or under their direct supervision if an equivalent level of safety is ensured.

Afterwards to be provided to the consumer to complete the cycle of use.

Not to be used on a person under 18 years of age.

(e)

Concentration of H2O2 present or released indicated in percentage.

Not to be used on a person under 18 years of age.

To be only sold to dental practitioners. For each cycle of use, the first use to be only done by dental practitioners or under their direct supervision if an equivalent level of safety is ensured.

Afterwards to be provided to the consumer to complete the cycle of use.

(f)

Products intended for eyelashes

(f)

2 % of H2O2, present or released

(f)

For professional use only

f)

To be printed on the label:

 

‘For professional use only.

 

Avoid contact with eyes.

 

Rinse eyes immediately if product comes into contact with them.

 

Contains hydrogen peroxide’

(c)

the following entries are added:

Ref No.

Substance identification

Restrictions

Wording of conditions of use and warnings

Chemical name/

INN

Name of Common Ingredients Glossary

CAS number

EC number

Product type, body parts

Maximum concentration in ready for use preparation

Other

 

a

b

c

d

e

f

g

h

i

‘311

Diphenyl(2,4,6-trimethylbenzoyl)phosphine oxide

Trimethylbenzoyl diphenylphosphine oxide

75980-60-8

278-355-8

Artificial nail systems

5,0 %

Professional use

For professional use only

Avoid skin contact

Read directions for use carefully

312

2-Furaldehyde

Furfural

98-01-1

202-627-7

 

0,001 %’

 

 

(3)   

Annex V is amended as follows:

(a)

point 2 of the preamble is replaced by the following:

‘2.

 All finished products containing substances in this Annex and which release formaldehyde must be labelled with the warning ‘contains formaldehyde’ where the concentration of formaldehyde in the finished product exceeds 0,05 %’

(b)

entries 5, 31, 40 and 41 are deleted;

(c)

entry 28 is replaced by the following:

Reference number

Substance Identification

Conditions

Wording of conditions of use and warnings

Chemical name/INN

Name of Common Ingredients Glossary

CAS number

EC number

Product type, Body parts

Maximum concentration in ready for use preparation

Other

 

a

b

c

d

e

f

g

h

i

‘28

Polyhexamethylene biguanide hydrochloride

Polyaminopropyl biguanide

32289-58-0,

27083-27-8,

28757-47-3,

133029-32-0

608-723-9

608-042-7

 

0,1 %

Not to be used in applications that may lead to exposure of the end-user's lungs by inhalation’

 

(*1)  Directive 2005/36/EC of the European Parliament and of the Council of 7 September 2005 on the recognition of professional qualifications (OJ L 255, 30.9.2005, p. 22).’;

Top